Overall, 14.6% had mutations in BRCA1 or BRCA2, 3.3% had mutations in other BRCA–Fanconi anemia genes (BRIP1, PALB2, RAD51C, RAD51D, BARD1), and 0.4% had mutations in mismatch repair genes linked to Lynch syndrome [10,11]. This evidence concerns the gene BRIP1 and Lynch syndrome.